The SCOPE trial

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 3, Issue 2, 2002, Pages 61-62

  Sever, Peter ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Cognitive function; Hypertension; Outcome trial

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ATENOLOL; CANDESARTAN; HYDROCHLOROTHIAZIDE; LOSARTAN; BENZIMIDAZOLE DERIVATIVE; TETRAZOLE DERIVATIVE;

AGED; CARDIOVASCULAR RISK; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EDITORIAL; HEART INFARCTION; HUMAN; HYPERTENSION; MORTALITY; OUTCOMES RESEARCH; PROGNOSIS; STROKE; COGNITIVE DEFECT; RANDOMIZED CONTROLLED TRIAL; REVIEW;

AGED; ANTIHYPERTENSIVE AGENTS; BENZIMIDAZOLES; COGNITION DISORDERS; HUMANS; HYPERTENSION; RANDOMIZED CONTROLLED TRIALS; TETRAZOLES;

EID: 0036614028     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.3317/jraas.2002.018     Document Type: Editorial

References (9)

1. Study on Cognition and Prognosis in the Elderly (SCOPE)
2. MRC trial of treatment of hypertension in older adults: Principal results
3. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension
4. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
5. Guidelines Sub-committee
6. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol
7. The Valsartan Antihypertensive Long-Term Use Evaluation (VALUE) trial of cardiovascular events in hypertension. Rationale and design
8. Rationale and design for the Antihypertensive and Lipid Lowering treatment to prevent Heart Attack Trial (ALLHAT)
9. Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial